Book Your Appointment


    Schedule An AppointmentClick Here
    phone-icon
    Quick EnquiryClick Now
    doctor-icon
    Contact UsIt's so fast
    phone-icon
    Live Tele ConsultationsSchedule It For Free

    Professor Nicholas Came from Ghana – Africa for Vision Loss – Stem Cell Care India

    Professor Nicholas Came from Ghana – Africa for Vision Loss – Stem Cell Care India

    ⏱ Estimated Reading Time: 2 minute(s) | 👁 169 views

    Hi, I am Professor Nicholas from Ghana. I am a professor of Statistics. I came to India for availing the
    stem cell treatment for vision loss via Stem Cell Care India. Few years back, I had stated encountering
    that my vision was deteriorating, both in terms of quality and sharpness. For getting the treatment, last
    year I travelled to China, where I was kept in the hospital for around 16 days and was charged a lot of
    money as well. However, I didn’t attain any relief. After this, I stated searching and exploring more
    about stem cell treatment. After my research, I decided to opt for Stem Cell Care India’s stem cell
    treatment for eyes in India. I contacted the hospital and they helped me a lot in imparting all the
    important information about the treatment to me. I realized that the cost of treatment in India is very
    much loss to what I had to pay in other nations. When I came to India, the treatment started and I was
    given vitamins and other medications. Stem cell treatment that I undergone was very simple and I got
    recovered very speedily. I experienced a lot of improvement in my eyesight. Also, the staff of the
    hospital is also very friendly, cooperative and caring.

    Andrew from Norway – Interstitial Lung Disease
    Miss Oluwatomiwa Ruth Akinniran I Nigeria I Developmental Delay, Treated by Stem cell Therapy

    Explore our Clinical Research Hub for scientific publications, treatment evidence, and ongoing regenerative medicine research.

    Content authored and reviewed by qualified members of our medical team | Last updated: 26 October 2018